Rejuvenate Bio

rejuvenatebio.com

Rejuvenate Bio is a biotechnology company focused on developing novel therapies to treat aging and age-related diseases through innovative targeted gene therapies. Originating from George Church's lab at Harvard Medical School, the company aims to address the significant health challenges posed by chronic diseases affecting a large portion of the American population. Their gene therapy pipeline is designed to provide effective treatments for both humans and animals, leveraging clinically validated gene targets to ensure long-lasting and well-tolerated gene expression. With a commitment to improving patient lives, Rejuvenate Bio is positioned to make a substantial impact in the healthcare sector.